Being part of Barclays Eagle Labs’ network it’s about connecting with a diverse ecosystem of entrepreneurs, corporate partners, and key stakeholders
We are excited to announce that Aisthesis Medical has been selected to participate in the prestigious Barclays Eagle Labs Funding Readiness Programme!
Why This Matters
This program, powered by Capital Enterprise, is specifically designed to support high-potential startups by providing comprehensive funding support, expert mentorship, and strategic advice to navigate the complexities of securing investment. By joining this program, we aim to refine our funding strategy and enhance our readiness for future investment rounds.
What the Programme Offers
The Funding Readiness Programme offers tailored workshops, one-on-one mentorship, and access to a vibrant community of industry experts and investors. Over the course of the program, we will gain insights on critical aspects of the investment process, from understanding investor expectations to building robust business models and financial projections. This guidance is invaluable as we seek to expand our impact in the healthcare technology space and accelerate the development of our cutting-edge solutions.
A Stronger Path to Scale and Growth
Being part of Barclays Eagle Labs’ network means more than just preparing for funding—it’s about connecting with a diverse ecosystem of entrepreneurs, corporate partners, and key stakeholders. As we focus on scaling our flagship product, VIOSync, the support from Eagle Labs will be crucial in strengthening our financial strategy and aligning our business model for sustainable growth.
Looking Ahead
Our goal is to leverage this opportunity to optimize our funding approach, secure strategic investments, and continue building transformative AI-driven solutions for healthcare. We look forward to working closely with the Eagle Labs mentors and fellow cohort members as we prepare for the next stages of our journey.
Learn more information about the Barclays Eagle Labs Funding Readiness Programme.
About Aisthesis Medical
Founded in 2022, Aisthesis Medical is an AI-driven healthcare technology company focused on enhancing clinical decision-making through predictive analytics. Our flagship product, VIOSync, predicts sepsis with 97% accuracy up to 48 hours before onset, enabling healthcare professionals to initiate treatment earlier, reducing ICU admissions, and improving patient outcomes.
Stay tuned as we continue on our mission to revolutionize acute care through predictive healthcare solutions!